Editorials

Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Pediatric Hematology/Oncology/BMT, BC Children's Hospital, Vancouver, British Columbia, Canada
Haematologica Early view May 26, 2022 https://doi.org/10.3324/haematol.2022.281114
Graft-versus-host disease